December 31, 2010Seracare Life Sciences Inc • January 13th, 2011 • In vitro & in vivo diagnostic substances
As we have discussed, your employment with SeraCare Life Sciences, Inc. (the "Company"), will terminate effective December 31, 2010 (the “Separation Date”). At this time, the company is extending this severance agreement offer to you. The purpose of this letter is to confirm this agreement between you and the Company concerning your severance arrangements, as follows:
